ROSUVASTATIN |
ZD4522 |
ZD-4522 |
(3R,5S,6E)-7-(4-(4-FLUOROPHENYL)-6-(1-METHYLETHYL)-2-(ETHYL(METHYLSULFONYL)AMINO)-5-PYRIMIDINYL)-3,5-DIHYDROXY-6-HEPTENOIC ACID |
(3R,5S,6E)-7-{4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO]PYRIMIDIN-5-YL}-3,5-DIHYDROXYHEPT-6-ENOIC ACID |
CRESTOR® |
pubchem.compound:446157 |
drugbank:01098 |
rxcui:301542 |
chembl:CHEMBL1496 |
chemidplus:287714-41-4 |
Year of Approval | 2003 |
Drug Class | anticholesteremic agents |
Drug Categories | sulfonamides |
Drug Categories | hydrocarbons, fluorinated |
Drug Categories | fluorobenzenes |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antihypecholesterolemic agent |
Drug Categories | agents causing muscle toxicity |
Drug Categories | alimentary tract and metabolism |
Drug Categories | benzene derivatives |
Drug Categories | bsep/abcb11 substrates |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 substrates (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a5 inhibitors |
Drug Categories | cytochrome p-450 cyp3a5 substrates |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | drugs used in diabetes |
Drug Categories | genito urinary system and sex hormones |
Drug Categories | gynecological antiinfectives and antiseptics |
Drug Categories | hypolipidemic agents indicated for hyperlipidemia |
Drug Categories | lipid modifying agents, plain |
Drug Categories | oat3/slc22a8 inhibitors |
Drug Categories | oat3/slc22a8 substrates |
Drug Categories | oatp1b1/slco1b1 inhibitors |
inhibitor (inhibitory) |
Specific Action of the Ligand | Competitive |
Endogenous Drug? | False |
Direct Interaction? | True |
ROSUVASTATIN | DrugBank Drug Name |
287714-41-4 | CAS Number |
Ach-rosuvastatin | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | agents causing muscle toxicity |
ROSUVASTATIN | Primary Drug Name |
Drug Class | anticholesteremic agents |
Year of Approval | 2003 |
Drug Indications | antihypecholesterolemic agent |
Drug Class | Small Molecule |
FDA Approval | approved |
ROSUVASTATIN | GuideToPharmacology Ligand Name |
D0JE2E | TTD Drug ID |